Oscient Pharmaceuticals Recieves FDA Approval, To Open 10% Up
Oscient Pharmaceuticals (OSCI) has announced that the company had recieved FDA approval for FACTIVE for 5-day treatment for community-acquired pneumonia (CAP).
Currently, FACTIVE is approved for a 7 day treatment for CAP and for a 5 day treatment for acute exacerbations of chronic bronchitis.
The stock is up almost 10% in pre-market action, and expect it open much higher by the time the bell rings.
_
Oscient Pharmaceuticals (OSCI) has announced that the company had recieved FDA approval for FACTIVE for 5-day treatment for community-acquired pneumonia (CAP).
Currently, FACTIVE is approved for a 7 day treatment for CAP and for a 5 day treatment for acute exacerbations of chronic bronchitis.
The stock is up almost 10% in pre-market action, and expect it open much higher by the time the bell rings.
_
posted by Nico at
8:43 AM
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home